Renaissance Technologies’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-159,950
Closed -$3.78M 4194
2023
Q4
$3.78M Buy
159,950
+46,500
+41% +$1.1M 0.01% 1529
2023
Q3
$1.69M Sell
113,450
-156,570
-58% -$2.34M ﹤0.01% 1963
2023
Q2
$2.96M Sell
270,020
-211,480
-44% -$2.32M ﹤0.01% 1748
2023
Q1
$4.2M Sell
481,500
-24,400
-5% -$213K 0.01% 1577
2022
Q4
$3.17M Buy
505,900
+15,100
+3% +$94.7K ﹤0.01% 1781
2022
Q3
$1.72M Sell
490,800
-23,820
-5% -$83.4K ﹤0.01% 2115
2022
Q2
$1.52M Buy
514,620
+55,085
+12% +$162K ﹤0.01% 2401
2022
Q1
$1.43M Buy
459,535
+243,915
+113% +$758K ﹤0.01% 2476
2021
Q4
$729K Sell
215,620
-296,971
-58% -$1M ﹤0.01% 2884
2021
Q3
$1.87M Sell
512,591
-283,629
-36% -$1.04M ﹤0.01% 2142
2021
Q2
$3.47M Sell
796,220
-93,943
-11% -$410K ﹤0.01% 1866
2021
Q1
$4.04M Buy
890,163
+480,443
+117% +$2.18M 0.01% 1788
2020
Q4
$2.35M Buy
409,720
+250,800
+158% +$1.44M ﹤0.01% 2023
2020
Q3
$1.15M Buy
158,920
+70,400
+80% +$510K ﹤0.01% 2441
2020
Q2
$309K Buy
+88,520
New +$309K ﹤0.01% 3032
2020
Q1
Sell
-424,840
Closed -$833K 3905
2019
Q4
$833K Buy
424,840
+384,920
+964% +$755K ﹤0.01% 2713
2019
Q3
$204K Buy
+39,920
New +$204K ﹤0.01% 3138
2018
Q2
Sell
-134,500
Closed -$1.75M 3604
2018
Q1
$1.75M Sell
134,500
-59,600
-31% -$774K ﹤0.01% 2394
2017
Q4
$1.79M Sell
194,100
-376,100
-66% -$3.46M ﹤0.01% 2409
2017
Q3
$4.6M Buy
570,200
+256,808
+82% +$2.07M 0.01% 1827
2017
Q2
$1.81M Buy
313,392
+81,443
+35% +$469K ﹤0.01% 2310
2017
Q1
$997K Buy
231,949
+114,549
+98% +$492K ﹤0.01% 2544
2016
Q4
$203K Sell
117,400
-3,400
-3% -$5.88K ﹤0.01% 3000
2016
Q3
$234K Sell
120,800
-7,500
-6% -$14.5K ﹤0.01% 3028
2016
Q2
$223K Buy
128,300
+17,300
+16% +$30.1K ﹤0.01% 3019
2016
Q1
$150K Buy
111,000
+50,100
+82% +$67.7K ﹤0.01% 3153
2015
Q4
$103K Buy
+60,900
New +$103K ﹤0.01% 3106